COTTBUS, Germany--(BUSINESS WIRE)--The Paulig Eye Surgery Centre announces today that it has acquired advanced technology for performing Keraflex KXL, a new, non-invasive, non-surgical treatment for ...

Please provide your email address to receive an email when new articles are posted on . Keratoconus is a personal area of interest. In this commentary, I will share a few of my current thoughts on the ...

BURLINGTON, Mass.--(BUSINESS WIRE)--Epion Therapeutics (Epion) announced the commencement of its Phase 3 Apricity trials for EpiSmart™, the company’s minimally-invasive keratoconus therapy. This marks ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

Please provide your email address to receive an email when new articles are posted on . A 54-year-old man was referred in late 2014 for a consultation for corneal transplant surgery in the left eye.

For most of his young life, the 15-year-old Wyoming High School sophomore ran into things, struggled with activities he enjoyed like catching a baseball and even found himself missing the other hand ...

On Monday, Glaukos Corporation (NYSE:GKOS) received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) acknowledging the previously submitted New Drug Application (NDA) for ...

Keratoconus is a disease that causes the cornea to slowly get thinner over time. It's the most common corneal dystrophy in the United States, affecting one in every 2,000 Americans. It is more common ...

To compare axial length (AL) with vitreous cavity length (VCL) in patients with keratoconus and to ascertain whether graft size can be tailored to reduce myopic ...

In a recent study published in Nature Biotechnology, researchers bioengineered corneal tissue for minimally invasive vision restoration. Study: Bioengineered corneal tissue for minimally invasive ...